Lecture 12 - Parkinson's Disease Flashcards

(46 cards)

1
Q

At what age do symptoms of Parkinson’s disease generally appear?

A

Around age 60

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the symptoms of Parkinson’s disease?

A
  • Rhythmic tremor - often occurs at first in one hand, resembles “pill rolling”
  • Leaning forward or backward when upright
  • Muscle rigidity - pushing on an arm causes it to move in jerky increments instead of smoothly
  • Difficulty rising from a sitting position
  • Speech*
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are marker’s of Parkinson’s disease?

A
  • Muscle rigidity
  • Slow movements
  • Loss of spontaneous movements
  • Resting tremor, first in one hand
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Which motor pathways control voluntary movement?

A
  • Upper motoneurons
  • Lower motoneurons
  • Corticospinal pathways
  • Pyramidal tracts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Which motor pathways control involuntary movement?

A
  • Extrapyramidal system
  • Basal ganglia
  • Reticular system
  • Vestibular system
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the neuropathophysiology of Parkinson’s disease?

A
  • Loss of neurons in substantia nigra causing loss of dopamine innervation of striatum
  • Balance btwn acetylcholine and dopamine is lost causing abnormal signalling and impaired mobility
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

At what stage of neuron loss do symptoms of Parkinson’s disease generally appear?

A

When about 70% of nigrostriatal neurons are lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What normally inhibits and excites GABA neurons?

A
  • Inhibited by dopamine

- Stimulated by acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Which symptoms of Parkinson’s disease are controllable by drug therapy?

A
  • Bradykinesia (slow initiation of movement)
  • Tremor at rest
  • Muscle rigidity
  • Abnormal posture
  • Early treatment for “neuronal sparing”
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the pharmacological targets of drugs for Parkinson’s disease?

A
  • Increase dopamine signalling in corpus striatum and substantia nigra
  • Decrease cholinergic activity
  • Decrease peripheral dopamine effects at D1/D2 dopamine receptors
  • Decrease peripheral L-DOPA metabolism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the function of COMT w/ respect to dopamine synthesis in substantia nigra?

A

Catalyzes L-DOPA -> 3-OMD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the function of DDC (dopa decarboxylase) w/ respect to dopamine synthesis in substantia nigra?

A

Catalyzes L-DOPA -> dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the function of TH (tyrosine hydroxylase) w/ respect to dopamine synthesis in substantia nigra?

A

Catalyzes tyrosine -> L-DOPA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does the D1 subfamily of dopamine receptors do?

A

Increases cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does the D2 subfamily of dopamine receptors do?

A

Decreases cAMP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are first line drugs to treat the early stage of Parkinson’s disease?

A
  • MAO-B inhibitors (rasagiline, selegiline)

- Levodopa (levodopa/carbidopa or levodopa/benserazide)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Does L-Dopa cross the BBB?

A

Yes, but only 1% enters the brain, causing side effects in the periphery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Where is L-Dopa metabolized?

A

Intestine, blood, and peripheral tissues

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What are the therapeutic effects of L-Dopa?

A
  • Reduces rigidity and bradykinesia
  • Improves motor function and speech
  • Return of facial expression
20
Q

What is the first choice drug for improving motor dysfunction from Parkinson’s disease?

21
Q

What is the most common side effect of L-Dopa that causes people to discontinue use of the drug?

A

Dyskinesias (abnormal involuntary movements)

22
Q

What are some side effects of L-Dopa besides dyskinesias?

A
  • Nausea, vomiting
  • Hypotension and cardiac arrhythmias
  • Wearing off
  • “On-off” effect
  • Insomnia, confusion
  • Psychosis, hallucinations
23
Q

What does carbidopa do?

A
  • Inhibits dopa decarboxylase (DDC) or aromatic L-amino acid decarboxylase (AADC)
  • Prevents breakdown of L-Dopa in periphery and allows more to cross BBB
24
Q

What are common adjunct therapies w/ L-Dopa?

A
  • L-Dopa and carbidopa = Sinemet

- L-Dopa and benserazide = Prolopa

25
What is entacapone used to treat?
- Later stage Parkinson's disease | - Used to treat problems associated w/ long term therapy of L-Dopa (wearing off, on-off effects)
26
What does entacapone do?
- Selective and reversible inhibitor of peripheral COMT causing reduction of peripheral metabolism of L-Dopa - Causes increased conversion of L-Dopa to dopamine in the brain
27
Does entacapone cross the BBB?
No
28
What is a disadvantage to entacapone?
Cause enhance adverse effects of L-Dopa like dyskinesias, nausea, psychosis, and confusion
29
What is entacapone normally used w/ and when?
- Sinemet (L-dopa + carbidopa) and entacapone = Stalevo | - Common use in pxs who have been on L-Dopa for over 10 years
30
What is amantadine?
Dopamine releaser
31
What are the therapeutic effects of amantadine?
- Increases dopamine release in CNS | - Reduce dyskinesia
32
When is amantadine used?
- Short term (under 6 months) | - Sometimes used w/ L-Dopa
33
What are the side effects of amantadine?
Similar to L-Dopa
34
What are ropinirole and pramipexole?
Selective dopamine agonists at D2/D3 receptors
35
What are the therapeutic effects of ropinirole and pramipexole?
- Act on D2 and D3 receptors in and outside of corpus striatum - Improves depressive symptoms - May be combined w/ L-Dopa to treat "on-off" effects
36
What are side effects of ropinirole and pramipexole and how can they be improved?
- Dyskinesia b/c act on D2 receptors outside of corpus striatum (dyskinesia is a result of peaks and troughs of drug delivery, so a patch will level out drug delivery and decrease dyskinesia) - Suppresses prolactin secretion - Hypotension - Visual and auditory hallucinations
37
What are some muscarinic antagonists used for Parkinson's disease treatment and what do they do?
- Trihexyphenidyl HCl - Benzatropine mesylate - Selective for muscarinic acetylcholine type 1 receptor
38
What are the therapeutic effects of muscarinic antagonists?
Tremors, but not rigidity (generally used in young px w/ severe tremor)
39
What is a contraindiction of trihexyphenidyl HCl and benzatropine mesylate?
Glaucoma
40
What does monoamine oxidase A do?
Metabolizes NE and serotonin
41
What does monoamine oxidase B do?
Metabolizes dopamine
42
What is selegiline?
Irreversible MAO B inhibitor
43
What does selegiline enhance the effects of?
L-Dopa
44
What are side effects of selegiline?
Insomina and cognitive problems
45
What occurs if selegiline is superceded by rasagiline?
- Less production of amphetamine-like by-products - Better bioavailability - Useful in px w/ depression and/or cognitive decline
46
What are some non-pharm therapeutics to treat Parkinson's disease?
- Surgery - ablation and/or deep brain stimulation (to inhibit STN and reduce dyskinesia) - Growth factors - Stem cells - replacement of dopaminergic neurons